Dafra Pharma: Clinical Trials

5 trials sponsored by Dafra Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 3 Phase 3, 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 11Completed 1
Phase 21Completed 1
Phase 41Completed 1

Follow Dafra Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni
Artesunate+Sulfamethoxypyrazine/pyrimethamine, Praziquantel - Schistosoma Mansoni
Phase 3CompletedKenya Medical Research Institute2122009-10-012010-01-22
Study of Artesunate in Metastatic Breast Cancer
artesunate - Metastatic Breast Cancer, Locally Advanced Breast Cancer
Phase 1CompletedHeidelberg University232008-10-012017-08-01
Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis
Artesunate+Sulfamethoxypyrazine/pyrimethamin, Praziquantel - Schistosoma Haematobium
Phase 2 / Phase 3CompletedDafra Pharma8002007-08-012008-01-18
Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria
Artemether/lumefantrine tablets, Artemether/Lumefantrine suspension - Malaria, Falciparum
Phase 4CompletedDafra Pharma2672007-05-012008-01-18
Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria
Co-Arinate FDC, Coartem - Plasmodium Falciparum Malaria
Phase 3CompletedDafra Pharma13902006-05-012008-03-26

Conditions studied

Malaria, Falciparum (2)  ·  Breast Neoplasms (1)  ·  Schistosomiasis (1)  ·  Schistosomiasis haematobia (1)

Interventions

Artemether, Lumefantrine Drug Combination (2)  ·  Praziquantel (2)  ·  Artemether (1)  ·  Artesunate (1)  ·  Lumefantrine (1)  ·  Pyrimethamine (1)

Countries

Kenya (2)  ·  Mali (2)  ·  Cameroon (1)  ·  Germany (1)  ·  Rwanda (1)  ·  Sudan (1)

Top investigators

Elizabeth A Juma, Dr. (1)  ·  Ishag A Adam, Dr (1)  ·  Issaka Sagara, Dr (1)  ·  Mahamadou S Sissoko, MD, MSPH (1)  ·  Pauline N Mwinzi, PhD (1)  ·  Stephen Rulisa, Dr (1)  ·  Wilfred F Mbacham, Dr (1)

Results publications

PMID 19102746, PMID 19366448, PMID 19802383, PMID 20705516, PMID 25248945, PMID 26793976, PMID 27094900, PMID 28439738, PMID 33289099